Status:
COMPLETED
Autonomous Digital CBT Intervention for Opioid Use Disorder in Individuals With Co-Occurring Internalizing Disorders
Lead Sponsor:
University of Minnesota
Conditions:
Opioid Use Disorder
Anxiety
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The primary objective of this protocol is to implement the UG3 phase (Phase 1) of a National Institute on Drug Abuse (NIDA) UG3/UH3 grant (RFA-DA-23-049). This phase is dedicated to the pilot testing ...
Eligibility Criteria
Inclusion
- Adults ages 18 to 65
- Current DSM-5 diagnosis of OUD (confirmed during MINI 7 interview)
- Current DSM-5 diagnosis of panic disorder with or without agoraphobia (PD/Ag) generalized anxiety disorder, social anxiety disorder, or major depression (confirmed during MINI 7 interview)
- Currently in treatment for OUD using MOUD
- Access to an internet-enabled smartphone for the duration of the study
- Currently residing in the United States
- Provision of informed consent
Exclusion
- Current diagnosis of psychosis
- Current institutionalization (e.g., jail, hospital)
- Self-reported pregnancy
- Non-English Speakers
Key Trial Info
Start Date :
August 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2025
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT06545071
Start Date
August 21 2025
End Date
December 14 2025
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455